Active Ingredient(s): Somatrem, Recombinant, rh-GH
FDA Approved: * October 17, 1985
Pharm Company: * GENENTECH
Category: Growth Hormone Treatment

Somatrem, sold under the brand name Protropin, is an analogue of growth hormone (GH).[1] Somatrem is a recombinant human growth hormone used for the treatment of short stature due to decreased or absent secretion of endogenous growth hormone. Somatrem was first marketed under the brand name Protropin by Genentech in 1985.[2] It differs from endogenous growth hormone by the addition of an extra methionine at the N-terminus[3][circular ref... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.